Physician

Amanda Bridget Dehlendorf, M.D.

According to 2025 Medicare claims, Amanda Dehlendorf, M.D. (NPI: 1871704270) practices rheumatology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Louis, MO. This provider's primary affiliated billing organization is ARTHRITIS CONSULTANTS INC. (NPI: 1770544066; TIN: 430947490) and primary practice location at 63141-6819. Dehlendorf is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616), participating under the MSSP model.

Dehlendorf's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 422 traditional Medicare patients, billed 97,249 HCPCS/CPT codes, and received $1,005,180 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,490 prescription claims across 752 beneficiaries totaling $1,711,155 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 29 records totaling $649. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,241,222 to $1,711,155. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	456	34,532	$760,912
2016	447	42,871	$857,108
2017	441	44,079	$916,667
2018	505	64,687	$1,089,445
2019	486	75,794	$1,068,087
2020	451	84,455	$1,079,747
2021	466	89,701	$1,053,911
2022	471	111,558	$1,111,353
2023	442	114,067	$1,064,483
2024	422	97,249	$1,005,180

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	521	4,668	$1,241,222
2016	542	3,387	$791,820
2017	512	3,049	$965,377
2018	530	3,123	$1,102,148
2019	538	2,944	$1,106,386
2020	595	3,322	$1,289,482
2021	643	3,398	$1,423,607
2022	761	3,714	$1,333,027
2023	778	3,491	$1,387,685
2024	752	3,490	$1,711,155

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	96	96	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	306	427	$87
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	49	323	$45
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	191	258	$12
36415	Insertion of needle into vein for collection of blood sample	119	267	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	40	1,260	$367,504
Enbrel Sureclick	Etanercept	34	1,176	$323,194
Rinvoq	Upadacitinib	32	1,200	$267,682
Xeljanz Xr	Tofacitinib Citrate	21	810	$154,344
Orencia Clickject	Abatacept	11	308	$62,419

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$649	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amanda Bridget Dehlendorf, M.D.?

Tedicare shows public-source Medicare data for Amanda Bridget Dehlendorf, M.D. (NPI 1871704270), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amanda Bridget Dehlendorf, M.D. have ACO affiliation data?

Amanda Bridget Dehlendorf, M.D. is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616).

What billing organization is linked to Amanda Bridget Dehlendorf, M.D.?

Amanda Bridget Dehlendorf, M.D. is linked to ARTHRITIS CONSULTANTS INC. (billing NPI 1770544066) in the available physician profile data.

Does Amanda Bridget Dehlendorf, M.D. have Open Payments data?

Amanda Bridget Dehlendorf, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.